Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.340
-0.010 (-0.74%)
Feb 19, 2026, 12:34 PM EST - Market open

INmune Bio Revenue

INmune Bio had revenue of $50.00K in the twelve months ending September 30, 2025, up 19.05% year-over-year. In the year 2024, INmune Bio had annual revenue of $14.00K, down -90.97%.

Revenue (ttm)
$50.00K
Revenue Growth
+19.05%
P/S Ratio
717.80
Revenue / Employee
$2,273
Employees
22
Market Cap
35.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Celularity40.58M
Xilio Therapeutics31.80M
Veru Inc.16.89M
Aligos Therapeutics2.65M
Pluri1.34M
Lisata Therapeutics1.07M
RenovoRx928.00K
ABVC BioPharma797.92K
Revenue Rankings

INMB News

More News